메뉴 건너뛰기




Volumn 27, Issue 7, 2006, Pages 761-763

Selection of the optimal reperfusion strategy for STEMI: Does time matter?

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

EID: 33645023300     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi775     Document Type: Editorial
Times cited : (32)

References (10)
  • 1
    • 33645027561 scopus 로고    scopus 로고
    • Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients
    • First published on March 2, 2006, doi:10.1093/eurheartj/ehi810
    • Boersma E, The Primary Coronary Angioplasty vs. Thrombolysis (PCAT)-2 Trialists' Collaborative Group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 2006;27:779-788. First published on March 2, 2006, doi:10.1093/eurheartj/ ehi810.
    • (2006) Eur Heart J , vol.27 , pp. 779-788
    • Boersma, E.1
  • 2
    • 0037417523 scopus 로고    scopus 로고
    • Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials
    • Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
    • (2003) Lancet , vol.361 , pp. 13-20
    • Keeley, E.C.1    Boura, J.A.2    Grines, C.L.3
  • 3
    • 13944271065 scopus 로고    scopus 로고
    • Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: Is the slope of the curve the shape of the future?
    • Gersh BJ, Stone GW, White HD, Holmes DR Jr. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA 2005;293:979-986.
    • (2005) JAMA , vol.293 , pp. 979-986
    • Gersh, B.J.1    Stone, G.W.2    White, H.D.3    Holmes Jr., D.R.4
  • 4
    • 0033662123 scopus 로고    scopus 로고
    • Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: The National Registry of Myocardial Infarction 1, 2 and 3
    • Rogers WJ, Canto JG, Lambrew CT, Tiefenbrunn AJ, Kinkaid B, Shoultz DA, Frederick PD, Every N. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 2000;36:2056-2063.
    • (2000) J Am Coll Cardiol , vol.36 , pp. 2056-2063
    • Rogers, W.J.1    Canto, J.G.2    Lambrew, C.T.3    Tiefenbrunn, A.J.4    Kinkaid, B.5    Shoultz, D.A.6    Frederick, P.D.7    Every, N.8
  • 5
    • 0043233236 scopus 로고    scopus 로고
    • Synergistic treatment of ST-segment elevation myocardial infarction with pharmacoinvasive recanalization
    • Dauerman HL, Sobel BE. Synergistic treatment of ST-segment elevation myocardial infarction with pharmacoinvasive recanalization. J Am Coll Cardiol 2003;42:646-651.
    • (2003) J Am Coll Cardiol , vol.42 , pp. 646-651
    • Dauerman, H.L.1    Sobel, B.E.2
  • 6
    • 33645033677 scopus 로고    scopus 로고
    • Impact of time to treatment with primary PCI on infarct size and myocardial reperfusion: Results from the EMERALD trial
    • Brodie B, Webb J, Cox D. Impact of time to treatment with primary PCI on infarct size and myocardial reperfusion: results from the EMERALD trial. Am J Cardiol 2005;96(7 Suppl. 1):TCT 141.
    • (2005) Am J Cardiol , vol.967 , Issue.1 SUPPL.
    • Brodie, B.1    Webb, J.2    Cox, D.3
  • 7
    • 3242760627 scopus 로고    scopus 로고
    • Aborted myocardial infarction in patients with ST-segment elevation: Insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy
    • Taher T, Fu Y, Wagner GS, Goodman SG, Fresco C, Granger CB, Wallentin L, Van de Werf F, Verheugt F, Armstrong PW. Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy. J Am Coll Cardiol 2004;44:38-43.
    • (2004) J Am Coll Cardiol , vol.44 , pp. 38-43
    • Taher, T.1    Fu, Y.2    Wagner, G.S.3    Goodman, S.G.4    Fresco, C.5    Granger, C.B.6    Wallentin, L.7    Van De Werf, F.8    Verheugt, F.9    Armstrong, P.W.10
  • 8
    • 0345060917 scopus 로고    scopus 로고
    • Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: Data from the CAPTIM randomized clinical trial
    • Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P, Leizorovicz A, Touboul P. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation 2003;108:2851-2856.
    • (2003) Circulation , vol.108 , pp. 2851-2856
    • Steg, P.G.1    Bonnefoy, E.2    Chabaud, S.3    Lapostolle, F.4    Dubien, P.Y.5    Cristofini, P.6    Leizorovicz, A.7    Touboul, P.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.